Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 81,538 | 12,420 | 13,622 | 3,127 | 8,912 |
| Gross Profit | 81,538 | 12,420 | 13,622 | 3,127 | 8,912 |
| Operating Expenses | 55,443 | 71,499 | 70,109 | 64,465 | 53,545 |
| Operating Income | 26,095 | -59,079 | -56,487 | -61,338 | -44,633 |
| Interest Expense | 0 | 0 | 0 | 0 | 535 |
| Other Income | -1,401 | 2,705 | 7,593 | 4,223 | 2,916 |
| Pre-tax Income | 24,694 | -56,374 | -48,894 | -57,115 | -42,252 |
| Income Tax | 150 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 24,544 | -56,374 | -48,894 | -57,115 | -42,252 |
| Net Income | $24,544 | $-56,374 | $-48,894 | $-57,115 | $-42,252 |
| EPS Basic Total Ops | 2.58 | -6.84 | -6.18 | -9.36 | -8.88 |
| EPS Basic Continuous Ops | 2.57 | -6.85 | -6.16 | -9.36 | -8.87 |
| EPS Diluted Total Ops | 2.52 | -6.84 | -6.18 | -9.36 | -8.88 |
| EPS Diluted Continuous Ops | 2.54 | -6.85 | -6.16 | -9.36 | -8.87 |
| EBITDA(a) | $28,116 | $-56,623 | $-53,658 | $-58,411 | $-41,571 |